Instil Bio, Inc. (TIL)

Instil Bio Statistics

Total Valuation

Instil Bio has a market cap or net worth of $174.03 million. The enterprise value is $167.09 million.

Market Cap	174.03M
Enterprise Value	167.09M

Important Dates

The next estimated earnings date is Wednesday, November 12, 2025, before market open.

Earnings Date	Nov 12, 2025
Ex-Dividend Date	n/a

Share Statistics

Instil Bio has 6.75 million shares outstanding. The number of shares has increased by 0.57% in one year.

Current Share Class	6.75M
Shares Outstanding	6.75M
Shares Change (YoY)	+0.57%
Shares Change (QoQ)	+0.98%
Owned by Insiders (%)	8.86%
Owned by Institutions (%)	29.38%
Float	3.31M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.32
P/TBV Ratio	1.32
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 14.97, with a Debt / Equity ratio of 0.64.

Current Ratio	14.97
Quick Ratio	6.63
Debt / Equity	0.64
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-7.02

Financial Efficiency

Return on equity (ROE) is -51.74% and return on invested capital (ROIC) is -13.58%.

Return on Equity (ROE)	-51.74%
Return on Assets (ROA)	-12.86%
Return on Invested Capital (ROIC)	-13.58%
Return on Capital Employed (ROCE)	-24.88%
Revenue Per Employee	n/a
Profits Per Employee	-$6.04M
Employee Count	14
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -69.50% in the last 52 weeks. The beta is 2.18, so Instil Bio's price volatility has been higher than the market average.

Beta (5Y)	2.18
52-Week Price Change	-69.50%
50-Day Moving Average	26.82
200-Day Moving Average	22.73
Relative Strength Index (RSI)	47.60
Average Volume (20 Days)	144,618

Short Selling Information

The latest short interest is 950,366, so 14.08% of the outstanding shares have been sold short.

Short Interest	950,366
Short Previous Month	903,288
Short % of Shares Out	14.08%
Short % of Float	28.73%
Short Ratio (days to cover)	7.11

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-54.03M
Pretax Income	-123.32M
Net Income	-84.51M
EBITDA	-51.88M
EBIT	-54.03M
Earnings Per Share (EPS)	-$12.92

Balance Sheet

The company has $91.82 million in cash and $84.88 million in debt, giving a net cash position of $6.94 million or $1.03 per share.

Cash & Cash Equivalents	91.82M
Total Debt	84.88M
Net Cash	6.94M
Net Cash Per Share	$1.03
Equity (Book Value)	131.67M
Book Value Per Share	19.50
Working Capital	193.53M

Cash Flow

Operating Cash Flow	-49.68M
Capital Expenditures	n/a
Free Cash Flow	-49.68M
FCF Per Share	-$7.36

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Instil Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.57%
Shareholder Yield	-0.57%
Earnings Yield	-48.56%
FCF Yield	-28.55%

Analyst Forecast

The average price target for Instil Bio is $120.50, which is 367.42% higher than the current price. The consensus rating is "Buy".

Price Target	$120.50
Price Target Difference	367.42%
Analyst Consensus	Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on December 8, 2023. It was a reverse split with a ratio of 1:20.

Last Split Date	Dec 8, 2023
Split Type	Reverse
Split Ratio	1:20

Scores

Altman Z-Score	n/a
Piotroski F-Score	1